Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types
Conditions: Non Small Cell Lung Cancer; Hepatocellular Carcinoma; Melanoma; Renal Cell Carcinoma; Microsatellite Instability High; Mismatch Repair Deficiency; Mesothelioma; Esophageal Squamous Cell Carcinoma; Squamous Cell Carcinoma of Head and Neck; Urothelial Carcinoma; Cervical Cancer Interventions: Drug: MT-8421; Drug: Nivolumab Sponsor: Molecular Templates, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Asbestosis | Cancer | Cancer & Oncology | Carcinoma | Melanoma | Mesothelioma | Research | Skin Cancer | Study